In this study, we demonstrated that CalebinA is effective even in gemcitabine-resistant pancreatic cancer cells, inhibiting tumor growth, angiogenesis, and invasion through suppression of NF-κB activity. This evidence concerns the gene NFKB1 and neoplasm.